Cleared Traditional

K031964 - BPCARD

K031964 is an FDA 510(k) clearance for BPCARD, manufactured by Qrs Diagnostic, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 72-day FDA review.

K031964 · Qrs Diagnostic, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2003
Decision
72d
Days
Class 2
Risk

K031964 is an FDA 510(k) clearance for the BPCARD. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Qrs Diagnostic, LLC (Plymouth, US). The FDA issued a Cleared decision on September 5, 2003 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Qrs Diagnostic, LLC devices

FDA 510(k) Submission Details - K031964

510(k) Number K031964 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2003
Decision Date September 05, 2003
Days to Decision 72 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 125d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 661
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K031964.
HL888BF
K032695 · Health & Life Co., Ltd. · Oct 2003
HL888 AF
K032913 · Health & Life Co., Ltd. · Oct 2003
BLOOD PRESSURE MONITOR, MODEL KP-7000
K032492 · K-Jump Health Co., Ltd. · Sep 2003
HL168R
K031695 · Health & Life Co., Ltd. · Jul 2003
HL888RA
K031835 · Health & Life Co., Ltd. · Jul 2003
AMBULATORY BLOOD PRESSURE (ABP) 92506 REPORT MANAGEMENT SYSTEM (RMS), MODEL 92506
K031479 · Datex-Ohmeda, Inc. · Jun 2003